MOA Life Plus Co. Ltd. Logo

MOA Life Plus Co. Ltd.

Develops immunotherapies & consumer solutions for immunity, skin rejuvenation, and pet care.

142760 | KO

Overview

Corporate Details

ISIN(s):
KR7142760008
LEI:
Country:
South Korea
Address:
경기도 용인시 수지구 신수로 767 7층 (동천동, 분당수지유타워 지식산업센터), 용인시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

MOA Life Plus Co. Ltd. (formerly BioLeaders Corp.) is a biopharmaceutical and healthcare company focused on developing innovative treatments and consumer products. The company's pharmaceutical division develops biopharmaceuticals, including immunotherapies, cancer treatments, and vaccines, utilizing a proprietary platform technology based on poly-gamma-glutamic acid (γ-PGA) and probiotics to enhance immune responses. Its clinical pipeline includes candidates for conditions such as cervical cancer and muscular dystrophy. The consumer business division provides tailored, clinically researched solutions for immunity enhancement, skin rejuvenation, and pet healthcare. The company supports its innovations with an extensive portfolio of domestic and international patents.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-12 00:00
Capital/Financing Update
[기재정정]주요사항보고서(자기전환사채매도결정)
Korean 45.4 KB
2025-08-18 00:00
Legal Proceedings Report
파생상품거래손실발생
Korean 6.5 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.6 MB
2025-08-11 00:00
Post-Annual General Meeting Information
임시주주총회결과
Korean 7.6 KB
2025-07-29 00:00
Capital/Financing Update
전환사채(해외전환사채포함)발행후만기전사채취득
Korean 11.8 KB
2025-07-24 00:00
Pre-Annual General Meeting Information
[기재정정]주주총회소집결의 (임시주주총회)
Korean 12.2 KB
2025-07-24 00:00
Pre-Annual General Meeting Information
[기재정정]주주총회소집결의 (임시주주총회)
Korean 11.2 KB
2025-07-24 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 72.5 KB
2025-07-24 00:00
Proxy Solicitation & Information Statement
의결권대리행사권유참고서류
Korean 37.3 KB
2025-07-18 00:00
Capital/Financing Update
타인에대한채무보증결정
Korean 20.0 KB
2025-07-18 00:00
Related Party Transaction
[기재정정]타인에대한채무보증결정
Korean 24.4 KB
2025-07-10 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 70.8 KB
2025-07-02 00:00
Share Issue/Capital Change
전환가액의조정
Korean 16.6 KB
2025-07-01 00:00
Share Issue/Capital Change
전환청구권행사
Korean 12.9 KB
2025-06-26 00:00
Delisting Announcement
해산사유발생(종속회사의주요경영사항)
Korean 9.2 KB

Automate Your Workflow. Get a real-time feed of all MOA Life Plus Co. Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for MOA Life Plus Co. Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for MOA Life Plus Co. Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Faes Farma S.A. Logo
Develops and markets pharmaceuticals, like antihistamines, and animal nutrition products globally.
Spain
FAE
Fagron N.V. Logo
Supplies compounding ingredients and solutions for personalized medicine to healthcare professionals.
Belgium
FAGR
Farmak Logo
A pharmaceutical manufacturer and exporter of 400+ medicines to over 50 countries.
Ukraine
FARM
Farmsintez ao Logo
Produces APIs & hospital drugs for oncology & specialty diseases; offers contract services.
Russian Federation
LIFE
FATE THERAPEUTICS INC Logo
Develops off-the-shelf iPSC cell therapies for cancer and autoimmune diseases.
United States of America
FATE
FENNEC PHARMACEUTICALS INC. Logo
Prevents chemotherapy-induced hearing loss in children with its sole product, PEDMARK®.
United States of America
FENC
FibroBiologics, Inc. Logo
Clinical-stage biotech developing fibroblast cell therapies for chronic diseases.
United States of America
FBLG
FIBROGEN INC Logo
Biopharma developing first-in-class therapies for cancer, anemia, and serious conditions.
United States of America
FGEN
Fine Foods & Pharmaceuticals Ntm Logo
Contract development & manufacturing of oral solids for pharma, nutraceutical & cosmetic sectors.
Italy
FF
Flora Growth Corp. Logo
A diversified firm in pharma distribution, plant-based wellness, and digital assets.
United States of America
FLGC

Talk to a Data Expert

Have a question? We'll get back to you promptly.